Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sorry flipper my answer does not fit the context.
Believe you have talked about failed studies and I have only seen the comparison of the stock exchanges. Excuse me
In my opinion, it does not matter if the stock is traded on the Nasdaq or OTC. See Google or your example Roche.
The problem in my opinion is that the stock is traded on far too few stock exchanges in Europe. In Stuttgard, for example, the difference between ask and bit is sometimes 15%. I think, this circumstance and the low price will prevent many reputable buyers from buying the stock.
If already known, I apologize for the renewed contribution
Presseportal
Journal of Translational Medicine
If you can buy the shares in Stuttgart, you can buy them from 8:00 am to 10:00 pm European time. The bid and ask are unfortunately far apart. Before buying or selling you should convert the price from Euro to Dollar.
https://www.boerse-stuttgart.de/de/boersenportal/wertpapiere-und-maerkte/aktien/factsheet/?ID_NOTATION=97117233
yes! Nwbo is listed in Stuttgart
Thanks abeta,
Maybe this article is interesting, unfortunately not free.
http://www.nature.com/nrneurol/journal/vaop/ncurrent/full/nrneurol.2017.64.html?WT.feed_name=subjects_biotechnology
I hope too, so far I have only been able to observe small trades.
In Stuttgart this morning 184,000 shares were traded. 100,000 for 0.253 Euro and 84,000 for 0.229 Euro.
As far as I can remember, the trade of nwbo shares in Germany has almost always been low.
Is that already known? Then I apologize for posting it.
https://clinicaltrials.gov/ct2/show/NCT03014804?term=DCVax&rank=7
Thank you for your response.
Level II Quotes
Free Real-Time Stock Quotes, Live Stock Charts and Most Active Stocks - For NASDAQ, NYSE, AMEX Stocks and OTCBB Stocks
http://www.level2stockquotes.com/real-time-stock-quotes.html
Change the symbol for Google in NWBO an press the button go
If you have selected 1D 1min, the course will be updated every minute.
I tink it`s not delayed, may be some seconds or one minute?
Hope it helps a little
Oh, I think it's free,
From their headline
Thank you very much,
but isn't it delayed?
may be this site helps
http://www.level2stockquotes.com/real-time-stock-quotes.html
Hi longfelllow95
the german ticker is WKN: A1J5EY
Caladrius Could Claw Its Way Back To Relevance With Immunotherapy
Dec. 4, 2015 10:53 AM ET | About: Caladrius Biosciences, Inc. (CLBS)
Zach Hartman, PhD
http://seekingalpha.com/article/3733976-caladrius-could-claw-its-way-back-to-relevance-with-immunotherapy
Reports of an 'end to daily diabetes jabs' are premature
Thu, 26 Nov 2015 12:33:00 EST
http://www.ncbi.nlm.nih.gov/pubmedhealth/behindtheheadlines/news/2015-11-26-reports-of-an-end-to-daily-diabetes-jabs-are-premature/
Immunotherapy for type 1 diabetes deemed safe in first US trial
Novel therapy aims to use patients' own immune cells to protect cells that produce insulin
UNIVERSITY OF CALIFORNIA - SAN FRANCISCO
PUBLIC RELEASE: 25-NOV-2015
http://www.eurekalert.org/pub_releases/2015-11/uoc--ift112415.php
you are quite right.
The whole biotech sector seems to me a mystery at the moment.
But I think with PCT as a subsidiary of Caladrius we have a real chance
get along in the future without too strong dilution.
I also believe that PCT continues to increase.
Why else would they are looking for more qualified employees.
The other day I read an article on the high costs of personalized therapies the author saw the main problem in the costs, that most biotech companies produce their vaccinations by contractors.
Unfortunately, I find the link no longer.
Well, I think it takes time and patience and both are one thing , which have the fewest investors.
At the moment I can not purchase any more shares, but at this price I certainly not sell anything.
Here is an excerpt from an interesting article.
http://www.bioprocessintl.com/manufacturing/cell-therapies/mapping-success-for-commercial-cell-therapy-manufacturing/
Mapping Success for Commercial Cell Therapy Manufacturing
by Bob Preti, Ann M. Daus, Brian Hampson and Cenk Sumen
Thursday, October 15, 2015 1:08 pm
Cell Therapy Manufacturing Best Practices from PCT
Monday, November 2, 2015
Cell Therapy Manufacturing Best Practices from PCT
This article is the second in a series of weekly posts featuring cell therapy news and articles as reported by BioProcess International Magazine.
By: Leah Kinthaert
http://futurebiopharma.blogspot.de/2015/11/cell-therapy-manufacturing-best.html
Many thanks for your technical analysis
Cancer Cell-Therapy Companies Scale Up in Race to Lower Costs
19 November 2015
Makiko Kitamura / Bloomberg Business
- See more at: http://novamedica.com/media/theme_news/p/3740#sthash.ULnYDFQ9.dpuf
here the excerpt from the article, in which they mention Caladrius
Caladrius Biosciences Raised to “Buy” at Zacks Investment Research (CLBS)
November 20th, 2015 - 0 comments - Filed Under - by Faye Duncan
http://www.dakotafinancialnews.com/caladrius-biosciences-lifted-to-buy-at-zacks-investment-research-clbs/673894/
In this respect, I think you could be right, iclight
interesting article posted on an other board.
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published online 2014 Jan 6. doi: 10.3791/50561
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063547/
Thanks Pyrrhonian
Pyrrhonian thanks for your research.
I am still invested here and I still believe in the technology of NWBO.
Nevertheless, I 'm going to read your links and posts again and especially even investigate the topic again.
Thanks again for your thoughts.
But in this context I would like to thank all other users for their opinions. Very helpful for me.
Hey Pyrrhonian, many thanks for your honest opinion, which I cherish also in the other board.
GL Luna
Many thanks, this is helpful for me.
I 'm going to read the
Hi Pyrrhonian,
Unfortunately, your post (NWBO post 44489) has been deleted.
in this post you had expressed your opinion about CLBS.
I think I have also read that you are re-invested.
I would be delighted if you could run your opinion on this in more detail.
hoping not outrageous act , Thanks in advance.
pity that the post was deleted, but it was not really important , nothing we did not know. But after a disappointing rise of the shareprice, despite good news I was pleased to read a positive opinion.
He said that he believes that CLBS in the package with PCT may very well be successful. Unfortunately he has not further elaborated, why.
And maybe I would prefer to write nice post, sorry.
About the current price development, I am also very disappointed.
Despite the good news in the red.
Thank you for your post Viperciara,
despite all the good news Wall Street seems to have disagreed.
But I am convinced that our time will come.
In my eyes, the share price is a joke.